SCHEMBL21682467

SCHEMBL21682467

NC(=O)C(=COc1ncccn1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.40
RAB9A P51151 5/20 0.40
PKM P14618 3/20 0.40
MITF O75030 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
KMT2A Q03164 3/20 0.39
CYP2C19 P33261 3/20 0.38
MAPT P10636 3/20 0.38
CYP3A4 P08684 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
POLB P06746 1/20 0.38
PARP1 P09874 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9995371 0.78 NPC1 (0.40) NPC1RAB9APKMMITFCDK5
SCHEMBL23422080 0.76 F7 (0.46) NPC1RAB9AKMT2AMAPTCYP3A4
SCHEMBL20995693 0.75 AKR1C1 (0.43) NPC1RAB9APKMMITFCDK5
SCHEMBL7149428 0.70 CES1 (0.41) NPC1RAB9APKMKMT2ACYP2C19
SCHEMBL94199 0.70 ALDH1A1 (0.42) NPC1RAB9APKMKMT2ACYP2C19
SCHEMBL94197 0.70 ALDH1A1 (0.42) NPC1RAB9APKMKMT2ACYP2C19
SCHEMBL517736 0.69 TSHR (0.52) PKMKMT2ACYP2C19MAPTCYP3A4
SCHEMBL1628733 0.69 TDP1 (0.52) PKMKMT2ACYP2C19MAPTCYP3A4
SCHEMBL517738 0.69 TSHR (0.52) PKMKMT2ACYP2C19MAPTCYP3A4
SCHEMBL8679701 0.69 TDP1 (0.52) PKMKMT2ACYP2C19MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833659-A1 PROCESS FOR MANUFACTURE OF (S)-N-(3-((2-((4-((1-ACETYLPYRROLIDIN-3-YL)(METHYL)AMINO)PHENYL)AMINO)-5-METHOXYPYRIMIDIN-4-YL)OXY) PHENYL)ACRYLAMIDE, AND FORMULATIONS THEREOF ACEA Therapeutics, Inc. (US) 2021-06-16 EP disclosed
WO-2020029156-A1 PROCESS FOR MANUFACTURE OF (S)-N-(3-((2-((4-((1-ACETYLPYRROLIDIN-3-YL)(METHYL)AMINO)PHENYL)AMINO)-5-METHOXYPYRIMIDIN-4-YL)OXY) PHENYL)ACRYLAMIDE, AND FORMULATIONS THEREOF ACEA Therapeutics, Inc. (US) 2020-02-13 WO disclosed